COVID-19’s outbreak has called for many industries to immediately change their approach towards the Pandemic. The industry most severely affected is the pharmaceutical industry and in lieu of this Barrister Shahrukh Iftikhar and his team at ABS & Co, have drawn up this alert outlining the influence of COVID-19 on medicine and therapeutic drugs. The alert aims to provide a better legal understanding of how the pharmaceutical industry is regulated and the measures being taken by different players to combat the virus, while giving country wise paradigms. It also takes into account the efforts being taken by companies in different countries to produce a vaccine and the future implications these companies may face in light of intellectual property law.
Access the brief on our LinkedIn. Alternatively, you can download the document using the link below.